<?xml version="1.0" encoding="UTF-8"?>





<rss xmlns:itunes="http://www.itunes.com/DTDs/Podcast-1.0.dtd" version="2.0">


 




	


 










 








	 	 
<channel>
<title>CROI 2015  - CROI 2015</title>
<itunes:author>CROI</itunes:author>
<description>CROI 2015  - CROI 2015: Oral Abstract Sessions</description>
<itunes:summary>CROI 2015  - CROI 2015: Oral Abstract Sessions</itunes:summary>    
<link>http://www.croiconference.org/</link>
<language>en-us</language>
<copyright>Copyright 2015, CROI. All Rights Reserved.</copyright>
<itunes:category>Podcasts</itunes:category>
 
         
<webMaster>support@capitalreach.com</webMaster>
 
        
  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25539.mp3?mediaType=feedmp3</link>
<description>
"Pragmatic Open-Label Randomised Trial of Preexposure Prophylaxis: The PROUD Study" by Sheena McCormack of MRC Clinical Trials Unit at University College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25539.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25539.mp3</guid>	
 
<itunes:summary>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?

"Pragmatic Open-Label Randomised Trial of Preexposure Prophylaxis: The PROUD Study" by Sheena McCormack of MRC Clinical Trials Unit at University College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25540.mp3?mediaType=feedmp3</link>
<description>
"On Demand PrEP With Oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial" by Jean-Michel Molina of University of Paris Diderot, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25540.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25540.mp3</guid>	
 
<itunes:summary>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?

"On Demand PrEP With Oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial" by Jean-Michel Molina of University of Paris Diderot, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25541.mp3?mediaType=feedmp3</link>
<description>
"Near Elimination of HIV Transmission in a Demonstration Project of PrEP and ART" by Jared Baeten of University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25541.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25541.mp3</guid>	
 
<itunes:summary>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?

"Near Elimination of HIV Transmission in a Demonstration Project of PrEP and ART" by Jared Baeten of University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25542.mp3?mediaType=feedmp3</link>
<description>
"Scale-Up of Preexposure Prophylaxis in San Francisco to Impact HIV Incidence" by Robert M. Grant of Gladstone Institutes, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25542.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25542.mp3</guid>	
 
<itunes:summary>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?

"Scale-Up of Preexposure Prophylaxis in San Francisco to Impact HIV Incidence" by Robert M. Grant of Gladstone Institutes, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25543.mp3?mediaType=feedmp3</link>
<description>
"FACTS 001 Phase III Trial of Pericoital Tenofovir 1% Gel for HIV Prevention in Women" by Helen Rees of Wits Reproductive Health and HIV Institute, Johannesburg, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25543.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25543.mp3</guid>	
 
<itunes:summary>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?

"FACTS 001 Phase III Trial of Pericoital Tenofovir 1% Gel for HIV Prevention in Women" by Helen Rees of Wits Reproductive Health and HIV Institute, Johannesburg, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25544.mp3?mediaType=feedmp3</link>
<description>
"Effect of Oral and Gel Tenofovir on Genital HSV Shedding in Immunocompetent Women" by Rachel A. Bender Ignacio of University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25544.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25544.mp3</guid>	
 
<itunes:summary>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?

"Effect of Oral and Gel Tenofovir on Genital HSV Shedding in Immunocompetent Women" by Rachel A. Bender Ignacio of University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25545.mp3?mediaType=feedmp3</link>
<description>
"Injectable Hormonal Contraception Use and Women’s Risk for HSV-2 Acquisition" by Mary K. Grabowski of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25545.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25545.mp3</guid>	
 
<itunes:summary>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?

"Injectable Hormonal Contraception Use and Women’s Risk for HSV-2 Acquisition" by Mary K. Grabowski of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25546.mp3?mediaType=feedmp3</link>
<description>
"Effect of Financial Incentives on Linkage to Care and Viral Suppression: HPTN 065" by Wafaa M. El-Sadr of ICAP at Columbia University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25546.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25546.mp3</guid>	
 
<itunes:summary>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?

"Effect of Financial Incentives on Linkage to Care and Viral Suppression: HPTN 065" by Wafaa M. El-Sadr of ICAP at Columbia University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25547.mp3?mediaType=feedmp3</link>
<description>
"Medical Male Circumcision of HIV-Infected Men Reduces Long-Term Penile HIV Shedding" by Jordyn L. Manucci of Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25547.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25547.mp3</guid>	
 
<itunes:summary>Oral Abstract: Preventing HIV and HSV-2: What Will It Take?

"Medical Male Circumcision of HIV-Infected Men Reduces Long-Term Penile HIV Shedding" by Jordyn L. Manucci of Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25551.mp3?mediaType=feedmp3</link>
<description>
"PROMISE: Efficacy and Safety of 2 Strategies to Prevent Perinatal HIV Transmission" by Mary Glenn Fowler of Johns Hopkins University School of Medicine/Makerere University–Johns Hopkins University Research Collaboration, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25551.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25551.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection

"PROMISE: Efficacy and Safety of 2 Strategies to Prevent Perinatal HIV Transmission" by Mary Glenn Fowler of Johns Hopkins University School of Medicine/Makerere University–Johns Hopkins University Research Collaboration, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25552.mp3?mediaType=feedmp3</link>
<description>
"Most Breastfeeding Women With High Viral Load Are Still Undiagnosed in Sub-Saharan Africa" by David Maman of Epicentre/Médecins Sans Frontières, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25552.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25552.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection

"Most Breastfeeding Women With High Viral Load Are Still Undiagnosed in Sub-Saharan Africa" by David Maman of Epicentre/Médecins Sans Frontières, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25553.mp3?mediaType=feedmp3</link>
<description>
"Delayed HIV Detection in Infants Exposed to ARV Prophylaxis During Breastfeeding" by Caroline C. King of US Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25553.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25553.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection

"Delayed HIV Detection in Infants Exposed to ARV Prophylaxis During Breastfeeding" by Caroline C. King of US Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25554.mp3?mediaType=feedmp3</link>
<description>
"Evaluation of the Alere q for Point-of-Care Early Infant HIV Diagnosis in South Africa" by Nei-Yuan Hsiao of University of Cape Town, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25554.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25554.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection

"Evaluation of the Alere q for Point-of-Care Early Infant HIV Diagnosis in South Africa" by Nei-Yuan Hsiao of University of Cape Town, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25555.mp3?mediaType=feedmp3</link>
<description>
"Early ART and Sustained Virological Suppression Limits HIV Proviral DNA Reservoir: CHER Evidence" by Helen A. Payne of University College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25555.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25555.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection

"Early ART and Sustained Virological Suppression Limits HIV Proviral DNA Reservoir: CHER Evidence" by Helen A. Payne of University College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25556.mp3?mediaType=feedmp3</link>
<description>
"Long-Term Outcomes of HIV-Infected Children Initiating NVP vs LPV/r-Based Treatment" by Linda Barlow-Mosha of Makerere University–Johns Hopkins University Research Collaboration, Kampala, Uganda
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25556.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25556.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection

"Long-Term Outcomes of HIV-Infected Children Initiating NVP vs LPV/r-Based Treatment" by Linda Barlow-Mosha of Makerere University–Johns Hopkins University Research Collaboration, Kampala, Uganda

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25557.mp3?mediaType=feedmp3</link>
<description>
"Structural Cardiovascular Changes Are Reversible in HIV-Infected Children in Zambia and Uganda." by Julia M. Kenny of University College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25557.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25557.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection

"Structural Cardiovascular Changes Are Reversible in HIV-Infected Children in Zambia and Uganda." by Julia M. Kenny of University College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25558.mp3?mediaType=feedmp3</link>
<description>
"ART With Weekends Off Is Noninferior to Continuous ART in Young People on EFV+2NRTI" by Karina M. Butler of Our Lady's Children's Hospital, Dublin, Ireland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25558.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25558.mp3</guid>	
 
<itunes:summary>Oral Abstract: Prevention, Diagnosis, and Treatment of Pediatric HIV Infection

"ART With Weekends Off Is Noninferior to Continuous ART in Young People on EFV+2NRTI" by Karina M. Butler of Our Lady's Children's Hospital, Dublin, Ireland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25562.mp3?mediaType=feedmp3</link>
<description>
"Envelope Trimer Numbers Required for Entry Steer HIV-1 Infectivity and Entry Kinetics" by Alexandra Trkola of University of Zurich, Zurich, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25562.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25562.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction

"Envelope Trimer Numbers Required for Entry Steer HIV-1 Infectivity and Entry Kinetics" by Alexandra Trkola of University of Zurich, Zurich, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25563.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 Accessory Protein Function: Evaluating VPU-Dependent Host Factor Degradation" by Prashant Jain of Sanford-Burnham Medical Research Institute, La Jolla, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25563.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25563.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction

"HIV-1 Accessory Protein Function: Evaluating VPU-Dependent Host Factor Degradation" by Prashant Jain of Sanford-Burnham Medical Research Institute, La Jolla, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25564.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 Adaptation to Humans Involved Interactions of Vpr With the DNA Damage Response" by Oliver I. Fregoso of Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25564.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25564.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction

"HIV-1 Adaptation to Humans Involved Interactions of Vpr With the DNA Damage Response" by Oliver I. Fregoso of Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25565.mp3?mediaType=feedmp3</link>
<description>
"The HIV-1 Protease Can Interact With RNA to Dramatically Enhance Its Activity" by Marc Potempa of University of North Carolina, Chapel Hill, NC
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25565.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25565.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction

"The HIV-1 Protease Can Interact With RNA to Dramatically Enhance Its Activity" by Marc Potempa of University of North Carolina, Chapel Hill, NC

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25566.mp3?mediaType=feedmp3</link>
<description>
"PQBP1 Is a Retrovirus-Specific Sensor Mediating cGAS/IRF3-Dependent Innate Responses" by Sunnie M. Yoh of Sanford-Burnham Medical Research Institute, La Jolla, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25566.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25566.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction

"PQBP1 Is a Retrovirus-Specific Sensor Mediating cGAS/IRF3-Dependent Innate Responses" by Sunnie M. Yoh of Sanford-Burnham Medical Research Institute, La Jolla, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25567.mp3?mediaType=feedmp3</link>
<description>
"Mucosal HIV-1 Transmission Specifically Selects for Type 1 Interferon-Resistant Viruses" by Shilpa Iyer of University of Pennsylvania, Philadelphia, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25567.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25567.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction

"Mucosal HIV-1 Transmission Specifically Selects for Type 1 Interferon-Resistant Viruses" by Shilpa Iyer of University of Pennsylvania, Philadelphia, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25568.mp3?mediaType=feedmp3</link>
<description>
"The Dynamics of HIV-1 RNA Near the Plasma Membrane During Virus Assembly" by Luca Sardo of Frederick National Laboratory for Cancer Research, Frederick, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25568.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25568.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction

"The Dynamics of HIV-1 RNA Near the Plasma Membrane During Virus Assembly" by Luca Sardo of Frederick National Laboratory for Cancer Research, Frederick, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25569.mp3?mediaType=feedmp3</link>
<description>
"Mechanisms of Dendritic Cell-Mediated Transfer of HIV-1 to CD4&lt;sup&gt;+ &lt;/sup&gt;T Lymphocytes" by Mickael M. Menager of Skirball Institute of Biomolecular Medicine, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25569.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25569.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cellular Dynamics, Sensing, and Viral Restriction

"Mechanisms of Dendritic Cell-Mediated Transfer of HIV-1 to CD4&lt;sup&gt;+ &lt;/sup&gt;T Lymphocytes" by Mickael M. Menager of Skirball Institute of Biomolecular Medicine, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Discoveries in HIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25573.mp3?mediaType=feedmp3</link>
<description>
"Inflammation Persists Despite Early Initiation of ART in Acute HIV Infection" by Netanya S. Utay of University of Texas Medical Branch at Galveston, Galveston, TX, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25573.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25573.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Discoveries in HIV Pathogenesis

"Inflammation Persists Despite Early Initiation of ART in Acute HIV Infection" by Netanya S. Utay of University of Texas Medical Branch at Galveston, Galveston, TX, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Discoveries in HIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25574.mp3?mediaType=feedmp3</link>
<description>
"HIV Burden and Biomarker Associations With Colonic HIV RNA During Acute HIV Infection" by Trevor A. Crowell of US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25574.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25574.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Discoveries in HIV Pathogenesis

"HIV Burden and Biomarker Associations With Colonic HIV RNA During Acute HIV Infection" by Trevor A. Crowell of US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Discoveries in HIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25575.mp3?mediaType=feedmp3</link>
<description>
"Identification and Characterization of Individual HIV-Infected CD4 T Cells Ex Vivo" by Joseph Casazza of Vaccine Research Center, NIAID, NIH, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25575.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25575.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Discoveries in HIV Pathogenesis

"Identification and Characterization of Individual HIV-Infected CD4 T Cells Ex Vivo" by Joseph Casazza of Vaccine Research Center, NIAID, NIH, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Discoveries in HIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25576.mp3?mediaType=feedmp3</link>
<description>
"Efficacy of HIV-1 Monoclonal Antibody Immunotherapy in Acute SHIV-Infected Macaques" by Diane L. Bolton of US Military HIV Research Program, Silver Spring, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25576.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25576.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Discoveries in HIV Pathogenesis

"Efficacy of HIV-1 Monoclonal Antibody Immunotherapy in Acute SHIV-Infected Macaques" by Diane L. Bolton of US Military HIV Research Program, Silver Spring, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Discoveries in HIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25577.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 Infections With Multiple Founders Are Associated With Higher Viral Loads" by Morgane Rolland of US Military HIV Research Program, Silver Spring, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25577.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25577.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Discoveries in HIV Pathogenesis

"HIV-1 Infections With Multiple Founders Are Associated With Higher Viral Loads" by Morgane Rolland of US Military HIV Research Program, Silver Spring, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Discoveries in HIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25578.mp3?mediaType=feedmp3</link>
<description>
"Post-Treatment Controllers Have Particular NK Cells With High Anti-HIV Capacity: VISCONTI Study" by Daniel Scott-Algara of Institut Pasteur, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25578.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25578.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Discoveries in HIV Pathogenesis

"Post-Treatment Controllers Have Particular NK Cells With High Anti-HIV Capacity: VISCONTI Study" by Daniel Scott-Algara of Institut Pasteur, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Discoveries in HIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25579.mp3?mediaType=feedmp3</link>
<description>
"Antiretroviral Therapy Preserves Polyfunctional HIV-1–Specific CD8 T Cells With Stem-Cell–Like Properties" by Selena Vigano of The Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25579.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25579.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Discoveries in HIV Pathogenesis

"Antiretroviral Therapy Preserves Polyfunctional HIV-1–Specific CD8 T Cells With Stem-Cell–Like Properties" by Selena Vigano of The Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Discoveries in HIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25580.mp3?mediaType=feedmp3</link>
<description>
"In Vitro Replication and Interferon-Alpha Resistance of Transmitted HIV-1 Variants" by Zachary Ende of Emory University, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25580.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25580.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Discoveries in HIV Pathogenesis

"In Vitro Replication and Interferon-Alpha Resistance of Transmitted HIV-1 Variants" by Zachary Ende of Emory University, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Discoveries in HIV Pathogenesis</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25581.mp3?mediaType=feedmp3</link>
<description>
"HVTN505 Breakthrough Sequences Show HIV Vaccine-Associated Differences in Env-gp120" by Morgane Rolland of US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Silver Spring, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25581.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25581.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Discoveries in HIV Pathogenesis

"HVTN505 Breakthrough Sequences Show HIV Vaccine-Associated Differences in Env-gp120" by Morgane Rolland of US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine Inc, Silver Spring, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25628.mp3?mediaType=feedmp3</link>
<description>
"Randomized Clinical Trial of Antiretroviral Therapy for Prevention of HAND" by Scott Letendre of University of California San Diego (UCSD), San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25628.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25628.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy

"Randomized Clinical Trial of Antiretroviral Therapy for Prevention of HAND" by Scott Letendre of University of California San Diego (UCSD), San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25629.mp3?mediaType=feedmp3</link>
<description>
"Neurocognitive Function in Africans Failing First-Line ART and Responses to Second Line" by Andrew D. Kambugu of Infectious Diseases Institute, Makerere University Kampala, Kampala, Uganda
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25629.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25629.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy

"Neurocognitive Function in Africans Failing First-Line ART and Responses to Second Line" by Andrew D. Kambugu of Infectious Diseases Institute, Makerere University Kampala, Kampala, Uganda

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25630.mp3?mediaType=feedmp3</link>
<description>
"Compartmentalized HIV Rebound in the CNS After ART Interruption" by Sara Gianella Weibel of University of California San Diego, La Jolla, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25630.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25630.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy

"Compartmentalized HIV Rebound in the CNS After ART Interruption" by Sara Gianella Weibel of University of California San Diego, La Jolla, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25631.mp3?mediaType=feedmp3</link>
<description>
"Impaired Blood-Brain Barrier Integrity Is Associated With Neuronal Injury in HIV" by Birgitta Anesten of University of Gothenburg, Gothenburg, Sweden
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25631.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25631.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy

"Impaired Blood-Brain Barrier Integrity Is Associated With Neuronal Injury in HIV" by Birgitta Anesten of University of Gothenburg, Gothenburg, Sweden

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25632.mp3?mediaType=feedmp3</link>
<description>
"Cortical and Subcortical Brain Volumes in Primary HIV Infection" by Patrick W. Wright of Washington University School of Medicine, Saint Louis, MO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25632.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25632.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy

"Cortical and Subcortical Brain Volumes in Primary HIV Infection" by Patrick W. Wright of Washington University School of Medicine, Saint Louis, MO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25633.mp3?mediaType=feedmp3</link>
<description>
"IRF4 Transcription Factor Associated With Integrated HIV DNA in Brain Macrophages" by Benjamin B. Gelman of University of Texas Medical Branch, Galveston, TX, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25633.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25633.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy

"IRF4 Transcription Factor Associated With Integrated HIV DNA in Brain Macrophages" by Benjamin B. Gelman of University of Texas Medical Branch, Galveston, TX, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25634.mp3?mediaType=feedmp3</link>
<description>
"Longitudinal Assessment of Blood Brain Barrier Disruption in Primary HIV Infection" by Elham Rahimy of Yale University School of Medicine, New Haven, CT, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25634.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25634.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy

"Longitudinal Assessment of Blood Brain Barrier Disruption in Primary HIV Infection" by Elham Rahimy of Yale University School of Medicine, New Haven, CT, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25635.mp3?mediaType=feedmp3</link>
<description>
"Declining Prevalence of HIV-Associated Neurocognitive Disorders in More Recent Years" by Andrea Antinori of National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, Italy
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25635.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25635.mp3</guid>	
 
<itunes:summary>Oral Abstract: NeuroAIDS Pathogenesis and Antiretroviral Therapy

"Declining Prevalence of HIV-Associated Neurocognitive Disorders in More Recent Years" by Andrea Antinori of National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, Italy

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25667.mp3?mediaType=feedmp3</link>
<description>
"Scientific Overview: The Clinical Pharmacology of HIV Prevention" by Marta Boffito of Chelsea and Westminster Hospital, NHS Foundation Trust/Imperial College, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25667.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25667.mp3</guid>	
 
<itunes:summary>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence

"Scientific Overview: The Clinical Pharmacology of HIV Prevention" by Marta Boffito of Chelsea and Westminster Hospital, NHS Foundation Trust/Imperial College, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25668.mp3?mediaType=feedmp3</link>
<description>
"Intracellular Pharmacokinetics of Sofosbuvir In Vivo" by Joseph Rower of University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25668.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25668.mp3</guid>	
 
<itunes:summary>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence

"Intracellular Pharmacokinetics of Sofosbuvir In Vivo" by Joseph Rower of University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25669.mp3?mediaType=feedmp3</link>
<description>
"Drug-Drug Interactions Between Anti-HCV Regimen Ledipasvir/Sofosbuvir and Antiretrovirals" by Polina German of Gilead Sciences, Inc., Foster City, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25669.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25669.mp3</guid>	
 
<itunes:summary>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence

"Drug-Drug Interactions Between Anti-HCV Regimen Ledipasvir/Sofosbuvir and Antiretrovirals" by Polina German of Gilead Sciences, Inc., Foster City, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25670.mp3?mediaType=feedmp3</link>
<description>
"Emtricitabine-Triphosphate in Dried Blood Spots (DBS) as a Marker of Recent Dosing" by Jose R. Castillo-Mancilla of University of Colorado-AMC, Aurora, CO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25670.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25670.mp3</guid>	
 
<itunes:summary>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence

"Emtricitabine-Triphosphate in Dried Blood Spots (DBS) as a Marker of Recent Dosing" by Jose R. Castillo-Mancilla of University of Colorado-AMC, Aurora, CO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25671.mp3?mediaType=feedmp3</link>
<description>
"Impact of EFV PK/PG on Neuropsychological Performance in Older HIV+ Patients" by Uriel S. Sandkovsky of University of Nebraska Medical Center, Omaha, NE, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25671.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25671.mp3</guid>	
 
<itunes:summary>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence

"Impact of EFV PK/PG on Neuropsychological Performance in Older HIV+ Patients" by Uriel S. Sandkovsky of University of Nebraska Medical Center, Omaha, NE, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25672.mp3?mediaType=feedmp3</link>
<description>
"Levonorgestrel Implant + EFV-Based ART: Unintended Pregnancies and Associated PK Data" by Kimberly K. Scarsi of University of Nebraska Medical Center, Omaha, NE, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25672.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25672.mp3</guid>	
 
<itunes:summary>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence

"Levonorgestrel Implant + EFV-Based ART: Unintended Pregnancies and Associated PK Data" by Kimberly K. Scarsi of University of Nebraska Medical Center, Omaha, NE, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25673.mp3?mediaType=feedmp3</link>
<description>
"A Phase IV PrEP Study Reveals Limited Ex Vivo Potency of Oral Maraviroc Against HIV-1" by Julie Fox of Guys and St Thomas' NHS Foundation Trust, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25673.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25673.mp3</guid>	
 
<itunes:summary>Oral Abstract: Intracellular and Clinical Pharmacology, Drug Interactions, and Adherence

"A Phase IV PrEP Study Reveals Limited Ex Vivo Potency of Oral Maraviroc Against HIV-1" by Julie Fox of Guys and St Thomas' NHS Foundation Trust, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25677.mp3?mediaType=feedmp3</link>
<description>
"Pomalidomide for Kaposi Sarcoma in People With and Without HIV: A Phase I/II Study" by Mark N. Polizzotto of National Cancer Institute (NCI), Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25677.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25677.mp3</guid>	
 
<itunes:summary>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs

"Pomalidomide for Kaposi Sarcoma in People With and Without HIV: A Phase I/II Study" by Mark N. Polizzotto of National Cancer Institute (NCI), Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25678.mp3?mediaType=feedmp3</link>
<description>
"Prognostic Model for Patients With Kaposi Sarcoma Treated With ART Alone in Africa" by Jeffrey Martin of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25678.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25678.mp3</guid>	
 
<itunes:summary>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs

"Prognostic Model for Patients With Kaposi Sarcoma Treated With ART Alone in Africa" by Jeffrey Martin of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25679.mp3?mediaType=feedmp3</link>
<description>
"One-Year Follow-up of HIV+ Women Screened With VIA, Cytology and HPV in South Africa" by Cynthia Firnhaber of University of Witswatersrand, Johannesburg, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25679.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25679.mp3</guid>	
 
<itunes:summary>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs

"One-Year Follow-up of HIV+ Women Screened With VIA, Cytology and HPV in South Africa" by Cynthia Firnhaber of University of Witswatersrand, Johannesburg, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25680.mp3?mediaType=feedmp3</link>
<description>
"High Rate of HSIL on HRA in HIV+ Women Not Meeting Criteria for Anal Cancer Screening" by Fanny Ita-Nagy of Icahn School of Medicine at Mount Sinai, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25680.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25680.mp3</guid>	
 
<itunes:summary>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs

"High Rate of HSIL on HRA in HIV+ Women Not Meeting Criteria for Anal Cancer Screening" by Fanny Ita-Nagy of Icahn School of Medicine at Mount Sinai, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25681.mp3?mediaType=feedmp3</link>
<description>
"Xpert MTB/RIF Ultra: A New Near-Patient TB Test With Sensitivity Equal to Culture" by David Alland of Rutgers New Jersey Medical School, Newark, NJ, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25681.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25681.mp3</guid>	
 
<itunes:summary>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs

"Xpert MTB/RIF Ultra: A New Near-Patient TB Test With Sensitivity Equal to Culture" by David Alland of Rutgers New Jersey Medical School, Newark, NJ, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25682.mp3?mediaType=feedmp3</link>
<description>
"Majority of XDR TB Cases Are Due to Transmission in a High-HIV-Prevalence Setting" by N. Sarita Shah of US Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25682.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25682.mp3</guid>	
 
<itunes:summary>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs

"Majority of XDR TB Cases Are Due to Transmission in a High-HIV-Prevalence Setting" by N. Sarita Shah of US Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25683.mp3?mediaType=feedmp3</link>
<description>
"Linkage to HIV/TB Care in South Africa: A Randomized Trial of Health Navigators" by Ingrid V. Bassett of Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25683.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25683.mp3</guid>	
 
<itunes:summary>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs

"Linkage to HIV/TB Care in South Africa: A Randomized Trial of Health Navigators" by Ingrid V. Bassett of Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25684.mp3?mediaType=feedmp3</link>
<description>
"Is It Safe to Stop Cotrimoxazole in Adults on ART: COSTOP, a Noninferiority RCT" by Jonathan B. Levin of MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25684.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25684.mp3</guid>	
 
<itunes:summary>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs

"Is It Safe to Stop Cotrimoxazole in Adults on ART: COSTOP, a Noninferiority RCT" by Jonathan B. Levin of MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25685.mp3?mediaType=feedmp3</link>
<description>
"High-Dose Rifampin, SQ109 and Moxifloxacin for Treating TB: The PanACEA MAMS-TB Trial" by Martin J. Boeree of Radboudumc, Nijmegen, Netherlands
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25685.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25685.mp3</guid>	
 
<itunes:summary>Oral Abstract: KS and Cervical/Anal Dysplasia: Tale of 2 Tumors and TB and Other OIs

"High-Dose Rifampin, SQ109 and Moxifloxacin for Treating TB: The PanACEA MAMS-TB Trial" by Martin J. Boeree of Radboudumc, Nijmegen, Netherlands

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25689.mp3?mediaType=feedmp3</link>
<description>
"Special Presentation: PEPFAR 3.0: Controlling the Epidemic and Delivering on the Promise of an AIDS-Free Generation" by Ambassador Deborah L. Birx, MD of US Department of State, Washington, DC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25689.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25689.mp3</guid>	
 
<itunes:summary>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective

"Special Presentation: PEPFAR 3.0: Controlling the Epidemic and Delivering on the Promise of an AIDS-Free Generation" by Ambassador Deborah L. Birx, MD of US Department of State, Washington, DC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25690.mp3?mediaType=feedmp3</link>
<description>
"Joint Estimation of HIV Progression and Survival: A Pooled Analysis of 25 Countries" by Tara D. Mangal of Imperial College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25690.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25690.mp3</guid>	
 
<itunes:summary>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective

"Joint Estimation of HIV Progression and Survival: A Pooled Analysis of 25 Countries" by Tara D. Mangal of Imperial College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25691.mp3?mediaType=feedmp3</link>
<description>
"Impact of Emergency Department HIV Testing and Linkage to Care: 25 Years' Experience" by Thomas C. Quinn of National Institute of Allergy and Infectious Diseases (NIAID), Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25691.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25691.mp3</guid>	
 
<itunes:summary>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective

"Impact of Emergency Department HIV Testing and Linkage to Care: 25 Years' Experience" by Thomas C. Quinn of National Institute of Allergy and Infectious Diseases (NIAID), Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25692.mp3?mediaType=feedmp3</link>
<description>
"Linkage to Care and Viral Suppression Among New HIV Diagnoses, New York City, 2006-13" by Lucia V. Torian of New York City Department of Health and Mental Hygiene, Long Island City, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25692.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25692.mp3</guid>	
 
<itunes:summary>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective

"Linkage to Care and Viral Suppression Among New HIV Diagnoses, New York City, 2006-13" by Lucia V. Torian of New York City Department of Health and Mental Hygiene, Long Island City, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25693.mp3?mediaType=feedmp3</link>
<description>
"Care and Viral Suppression Among Women, 18 US Jurisdictions" by Ndidi Ike of US Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25693.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25693.mp3</guid>	
 
<itunes:summary>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective

"Care and Viral Suppression Among Women, 18 US Jurisdictions" by Ndidi Ike of US Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25694.mp3?mediaType=feedmp3</link>
<description>
"Time Above 1500 Copies/ml: A Viral-Load Measure for Assessing Transmission Risk of HIV-Positive Patients in Care" by Lytt I. Gardner of Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25694.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25694.mp3</guid>	
 
<itunes:summary>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective

"Time Above 1500 Copies/ml: A Viral-Load Measure for Assessing Transmission Risk of HIV-Positive Patients in Care" by Lytt I. Gardner of Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25695.mp3?mediaType=feedmp3</link>
<description>
"Incidence and Risk Factors for Sexual Assault Among MSM and Young Women in Coastal Kenya" by Adrian D. Smith of Nuffield Department of Population Health, Oxford, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25695.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25695.mp3</guid>	
 
<itunes:summary>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective

"Incidence and Risk Factors for Sexual Assault Among MSM and Young Women in Coastal Kenya" by Adrian D. Smith of Nuffield Department of Population Health, Oxford, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25696.mp3?mediaType=feedmp3</link>
<description>
"Impact of the Ebola Epidemic on HIV Care in Macenta, Forest Guinea, 2014" by David Leuenberger of Mission Philafricaine, Conakry, Guinea
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25696.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25696.mp3</guid>	
 
<itunes:summary>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective

"Impact of the Ebola Epidemic on HIV Care in Macenta, Forest Guinea, 2014" by David Leuenberger of Mission Philafricaine, Conakry, Guinea

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25697.mp3?mediaType=feedmp3</link>
<description>
"Favipiravir in Patients with Ebola Virus Disease: Early Results of the JIKI trial in Guinea" by Denis Malvy of Université de Bordeaux, Bordeaux, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25697.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25697.mp3</guid>	
 
<itunes:summary>Oral Abstract: Factors Affecting HIV Care and Outcome: Global Perspective

"Favipiravir in Patients with Ebola Virus Disease: Early Results of the JIKI trial in Guinea" by Denis Malvy of Université de Bordeaux, Bordeaux, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25701.mp3?mediaType=feedmp3</link>
<description>
"Durable Control of Viral Rebound in Humanized Mice by ABX464 Targeting Rev Functions" by Jamal Tazi of University of Montpellier, Montpellier, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25701.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25701.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound

"Durable Control of Viral Rebound in Humanized Mice by ABX464 Targeting Rev Functions" by Jamal Tazi of University of Montpellier, Montpellier, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25702.mp3?mediaType=feedmp3</link>
<description>
"Residual Viremia Caused by Clonally Expanded Tumor-Infiltrating CD4+ Cells" by Francesco R. Simonetti of National Cancer Institute (NCI), Frederick, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25702.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25702.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound

"Residual Viremia Caused by Clonally Expanded Tumor-Infiltrating CD4+ Cells" by Francesco R. Simonetti of National Cancer Institute (NCI), Frederick, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25703.mp3?mediaType=feedmp3</link>
<description>
"Analysis of HIV RNA in Single Cells Reveals Clonal Expansions and Defective Genomes" by Mary F. Kearney of National Cancer Institute, Frederick, MD, MD
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25703.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25703.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound

"Analysis of HIV RNA in Single Cells Reveals Clonal Expansions and Defective Genomes" by Mary F. Kearney of National Cancer Institute, Frederick, MD, MD

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25704.mp3?mediaType=feedmp3</link>
<description>
"Low-Level HIV Viremias Originate in Part From Infected Proliferating Cells" by Marta E. Bull of University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25704.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25704.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound

"Low-Level HIV Viremias Originate in Part From Infected Proliferating Cells" by Marta E. Bull of University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25705.mp3?mediaType=feedmp3</link>
<description>
"Treatment With a TLR7 Agonist Induces Transient Viremia in SIV-Infected ART-Suppressed Monkeys" by James B. Whitney of Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25705.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25705.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound

"Treatment With a TLR7 Agonist Induces Transient Viremia in SIV-Infected ART-Suppressed Monkeys" by James B. Whitney of Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25706.mp3?mediaType=feedmp3</link>
<description>
"Panobinostat Broadly Activates Latent HIV-1 Proviruses in Patients" by Sarah E. Palmer of Westmead Millennium Institute and University of Sydney, Westmead, Australia
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25706.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25706.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound

"Panobinostat Broadly Activates Latent HIV-1 Proviruses in Patients" by Sarah E. Palmer of Westmead Millennium Institute and University of Sydney, Westmead, Australia

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25707.mp3?mediaType=feedmp3</link>
<description>
"The Size of the Active HIV Reservoir Predicts Timing of Viral Rebound" by Jonathan Li of Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25707.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25707.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound

"The Size of the Active HIV Reservoir Predicts Timing of Viral Rebound" by Jonathan Li of Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25708.mp3?mediaType=feedmp3</link>
<description>
"Biomarkers to Predict Viral Rebound at Antiretroviral Therapy Interruption in SPARTAC" by John Frater of University of Oxford, Oxford, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25708.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25708.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound

"Biomarkers to Predict Viral Rebound at Antiretroviral Therapy Interruption in SPARTAC" by John Frater of University of Oxford, Oxford, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25709.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 Diversity and Tropism of Rebound Virus After Treatment Discontinuation" by Maria M. Bednar of University of North Carolina, Durham, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25709.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25709.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Insights Into HIV Persistence, Latency Reversal, and Viremia Rebound

"HIV-1 Diversity and Tropism of Rebound Virus After Treatment Discontinuation" by Maria M. Bednar of University of North Carolina, Durham, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25755.mp3?mediaType=feedmp3</link>
<description>
"Tenofovir Alafenamide (TAF) in a Single-Tablet Regimen in Initial HIV-1 Therapy" by David Wohl of University of North Carolina, Chapel Hill, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25755.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25755.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance

"Tenofovir Alafenamide (TAF) in a Single-Tablet Regimen in Initial HIV-1 Therapy" by David Wohl of University of North Carolina, Chapel Hill, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25756.mp3?mediaType=feedmp3</link>
<description>
"Antiviral Activity/Safety of a Second-Generation HIV-1 Maturation Inhibitor" by Max Lataillade of Bristol-Myers Squibb, Wallingford, CT, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25756.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25756.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance

"Antiviral Activity/Safety of a Second-Generation HIV-1 Maturation Inhibitor" by Max Lataillade of Bristol-Myers Squibb, Wallingford, CT, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25757.mp3?mediaType=feedmp3</link>
<description>
"Early ART and IPT in HIV-Infected African Adults With High CD4 Count (Temprano Trial)" by Christine Danel of Inserm, Bordeaux, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25757.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25757.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance

"Early ART and IPT in HIV-Infected African Adults With High CD4 Count (Temprano Trial)" by Christine Danel of Inserm, Bordeaux, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25758.mp3?mediaType=feedmp3</link>
<description>
"Antiretroviral Drug Screening Provides Key Insights Into HIV Drug Resistance" by Iris Chen of Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25758.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25758.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance

"Antiretroviral Drug Screening Provides Key Insights Into HIV Drug Resistance" by Iris Chen of Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25759.mp3?mediaType=feedmp3</link>
<description>
"Untimed Drug Levels and Resistance in Patients Experiencing Low-Level HIV Viremia" by Alejandro Gonzalez-Serna of BC Centre for Excellence in HIV/AIDS, Vancouver, Canada
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25759.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25759.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance

"Untimed Drug Levels and Resistance in Patients Experiencing Low-Level HIV Viremia" by Alejandro Gonzalez-Serna of BC Centre for Excellence in HIV/AIDS, Vancouver, Canada

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25760.mp3?mediaType=feedmp3</link>
<description>
"Pretreatment HIV Drug Resistance Increases Regimen Switch in Sub-Saharan Africa" by Tamara Sonia Boender of Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25760.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25760.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance

"Pretreatment HIV Drug Resistance Increases Regimen Switch in Sub-Saharan Africa" by Tamara Sonia Boender of Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25761.mp3?mediaType=feedmp3</link>
<description>
"Impact of NRTI Cross-Resistance on Second-Line PI + NRTI Therapy Outcomes in Africa" by Nicholas Paton of National University of Singapore, Singapore, Singapore
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25761.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25761.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance

"Impact of NRTI Cross-Resistance on Second-Line PI + NRTI Therapy Outcomes in Africa" by Nicholas Paton of National University of Singapore, Singapore, Singapore

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25762.mp3?mediaType=feedmp3</link>
<description>
"Fitness Effects of Drug-Resistant Strains Across the United States HIV-1 Transmission Network" by Joel O. Wertheim of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25762.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25762.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance

"Fitness Effects of Drug-Resistant Strains Across the United States HIV-1 Transmission Network" by Joel O. Wertheim of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25763.mp3?mediaType=feedmp3</link>
<description>
"Dolutegravir Resistance Requires Multiple Primary Mutations in HIV-1 Integrase" by Wei Huang of Monogram Biosciences, South San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25763.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25763.mp3</guid>	
 
<itunes:summary>Oral Abstract: New Antiretroviral Agents, Strategies, and HIV Drug Resistance

"Dolutegravir Resistance Requires Multiple Primary Mutations in HIV-1 Integrase" by Wei Huang of Monogram Biosciences, South San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cardiovascular, Bone, and Kidney Health</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25789.mp3?mediaType=feedmp3</link>
<description>
"Moderator" by Edgar T. Overton of University of Alabama at Birmingham, Birmingham, AL, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25789.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25789.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cardiovascular, Bone, and Kidney Health

"Moderator" by Edgar T. Overton of University of Alabama at Birmingham, Birmingham, AL, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cardiovascular, Bone, and Kidney Health</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25790.mp3?mediaType=feedmp3</link>
<description>
"Statin Therapy Reduces Coronary Noncalcified Plaque Volume in HIV Patients: A Randomized Controlled Trial" by Janet Lo of Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25790.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25790.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cardiovascular, Bone, and Kidney Health

"Statin Therapy Reduces Coronary Noncalcified Plaque Volume in HIV Patients: A Randomized Controlled Trial" by Janet Lo of Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cardiovascular, Bone, and Kidney Health</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25791.mp3?mediaType=feedmp3</link>
<description>
"Rosuvastatin Arrests Progression of Carotid Intima-Media Thickness in Treated HIV" by Grace A. McComsey of Case Western Reserve University, Cleveland, OH, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25791.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25791.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cardiovascular, Bone, and Kidney Health

"Rosuvastatin Arrests Progression of Carotid Intima-Media Thickness in Treated HIV" by Grace A. McComsey of Case Western Reserve University, Cleveland, OH, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cardiovascular, Bone, and Kidney Health</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25792.mp3?mediaType=feedmp3</link>
<description>
"Calcified Plaque Burden Is Associated With Serum Gut Microbiota-Generated TMA in HIV" by Suman Srinivasa of Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25792.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25792.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cardiovascular, Bone, and Kidney Health

"Calcified Plaque Burden Is Associated With Serum Gut Microbiota-Generated TMA in HIV" by Suman Srinivasa of Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cardiovascular, Bone, and Kidney Health</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25793.mp3?mediaType=feedmp3</link>
<description>
"Varenicline vs Placebo for Smoking Cessation: ANRS 144 Inter-ACTIV Randomized Trial" by Patrick Mercie of Hosp. Saint-André, Bordeaux, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25793.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25793.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cardiovascular, Bone, and Kidney Health

"Varenicline vs Placebo for Smoking Cessation: ANRS 144 Inter-ACTIV Randomized Trial" by Patrick Mercie of Hosp. Saint-André, Bordeaux, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cardiovascular, Bone, and Kidney Health</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25794.mp3?mediaType=feedmp3</link>
<description>
"Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors" by Grace A. McComsey of Case Western Reserve University, Cleveland, OH, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25794.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25794.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cardiovascular, Bone, and Kidney Health

"Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors" by Grace A. McComsey of Case Western Reserve University, Cleveland, OH, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cardiovascular, Bone, and Kidney Health</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25795.mp3?mediaType=feedmp3</link>
<description>
"Fracture Prediction With Modified FRAX in Older HIV+ and HIV- Men" by Michael T. Yin of Columbia University Medical Center, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25795.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25795.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cardiovascular, Bone, and Kidney Health

"Fracture Prediction With Modified FRAX in Older HIV+ and HIV- Men" by Michael T. Yin of Columbia University Medical Center, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cardiovascular, Bone, and Kidney Health</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25796.mp3?mediaType=feedmp3</link>
<description>
"Exposure to Antiretrovirals (ARVs) and Development of Chronic Kidney Disease (CKD)" by Amanda Mocroft of University College London, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25796.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25796.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cardiovascular, Bone, and Kidney Health

"Exposure to Antiretrovirals (ARVs) and Development of Chronic Kidney Disease (CKD)" by Amanda Mocroft of University College London, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cardiovascular, Bone, and Kidney Health</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25797.mp3?mediaType=feedmp3</link>
<description>
"Renal and Bone Safety of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate" by Paul E. Sax of Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25797.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25797.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cardiovascular, Bone, and Kidney Health

"Renal and Bone Safety of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate" by Paul E. Sax of Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Cardiovascular, Bone, and Kidney Health</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25798.mp3?mediaType=feedmp3</link>
<description>
"Special Presentation: Update on National Heart, Lung, and Blood Institute High-Impact AIDS Research" by Monica Shah of National Heart, Lung, and Blood Institute, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25798.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25798.mp3</guid>	
 
<itunes:summary>Oral Abstract: Cardiovascular, Bone, and Kidney Health

"Special Presentation: Update on National Heart, Lung, and Blood Institute High-Impact AIDS Research" by Monica Shah of National Heart, Lung, and Blood Institute, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Curing HCV: Mission Accomplished</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25802.mp3?mediaType=feedmp3</link>
<description>
"The Burden of Liver Disease Among Persons With Hepatitis C in the United States" by Monina Klevens of US Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25802.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25802.mp3</guid>	
 
<itunes:summary>Oral Abstract: Curing HCV: Mission Accomplished

"The Burden of Liver Disease Among Persons With Hepatitis C in the United States" by Monina Klevens of US Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Curing HCV: Mission Accomplished</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25803.mp3?mediaType=feedmp3</link>
<description>
"High Efficacy of Daclatasvir/Asunaprevir/PR in HIV/HCV1-4 Null Responders (ANRS HC30)" by Lionel Piroth of CHU Dijon, Dijon, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25803.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25803.mp3</guid>	
 
<itunes:summary>Oral Abstract: Curing HCV: Mission Accomplished

"High Efficacy of Daclatasvir/Asunaprevir/PR in HIV/HCV1-4 Null Responders (ANRS HC30)" by Lionel Piroth of CHU Dijon, Dijon, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Curing HCV: Mission Accomplished</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25804.mp3?mediaType=feedmp3</link>
<description>
"High SVR Regardless of Time to Suppression With ABT-450/r/Ombitasvir &amp; Dasabuvir+RBV" by David Wyles of University of California San Diego, La Jolla, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25804.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25804.mp3</guid>	
 
<itunes:summary>Oral Abstract: Curing HCV: Mission Accomplished

"High SVR Regardless of Time to Suppression With ABT-450/r/Ombitasvir &amp; Dasabuvir+RBV" by David Wyles of University of California San Diego, La Jolla, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Curing HCV: Mission Accomplished</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25805.mp3?mediaType=feedmp3</link>
<description>
"The Paradox of Highly Effective Sofosbuvir Combo Therapy Despite Slow Viral Decline" by Jérémie Guedj of IAME, UMR 1137, Inserm, F-75018; Univ Paris Diderot, Sorbonne Paris Cité, F-75018, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25805.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25805.mp3</guid>	
 
<itunes:summary>Oral Abstract: Curing HCV: Mission Accomplished

"The Paradox of Highly Effective Sofosbuvir Combo Therapy Despite Slow Viral Decline" by Jérémie Guedj of IAME, UMR 1137, Inserm, F-75018; Univ Paris Diderot, Sorbonne Paris Cité, F-75018, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Curing HCV: Mission Accomplished</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25806.mp3?mediaType=feedmp3</link>
<description>
"Real-World Pharmaceutical Costs in the Simeprevir/Sofosbuvir Era: $164,485 per SVR4" by Kian Bichoupan of Mount Sinai School of Medicine, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25806.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25806.mp3</guid>	
 
<itunes:summary>Oral Abstract: Curing HCV: Mission Accomplished

"Real-World Pharmaceutical Costs in the Simeprevir/Sofosbuvir Era: $164,485 per SVR4" by Kian Bichoupan of Mount Sinai School of Medicine, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Curing HCV: Mission Accomplished</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25807.mp3?mediaType=feedmp3</link>
<description>
"Impact of Deferring HCV Treatment on Liver-Related Events in HIV+ Patients" by Cindy Zahnd of Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25807.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25807.mp3</guid>	
 
<itunes:summary>Oral Abstract: Curing HCV: Mission Accomplished

"Impact of Deferring HCV Treatment on Liver-Related Events in HIV+ Patients" by Cindy Zahnd of Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Curing HCV: Mission Accomplished</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25808.mp3?mediaType=feedmp3</link>
<description>
"Daclatasvir in Combination With Sofosbuvir for HIV/HCV Coinfection: ALLY-2 Study" by David Wyles of University of California San Diego, La Jolla, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25808.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25808.mp3</guid>	
 
<itunes:summary>Oral Abstract: Curing HCV: Mission Accomplished

"Daclatasvir in Combination With Sofosbuvir for HIV/HCV Coinfection: ALLY-2 Study" by David Wyles of University of California San Diego, La Jolla, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Curing HCV: Mission Accomplished</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25809.mp3?mediaType=feedmp3</link>
<description>
"Ledipasvir/Sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1" by Susanna Naggie of Duke Clinical Research Institute, Durham, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25809.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25809.mp3</guid>	
 
<itunes:summary>Oral Abstract: Curing HCV: Mission Accomplished

"Ledipasvir/Sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1" by Susanna Naggie of Duke Clinical Research Institute, Durham, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Reaching Populations: Demonstrating Impact</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25813.mp3?mediaType=feedmp3</link>
<description>
"Population Viral Load in Three High HIV Prevalence Settings in Sub-Saharan Africa" by David Maman of Epicentre/Médecins Sans Frontières, Paris, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25813.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25813.mp3</guid>	
 
<itunes:summary>Oral Abstract: Reaching Populations: Demonstrating Impact

"Population Viral Load in Three High HIV Prevalence Settings in Sub-Saharan Africa" by David Maman of Epicentre/Médecins Sans Frontières, Paris, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Reaching Populations: Demonstrating Impact</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25814.mp3?mediaType=feedmp3</link>
<description>
"Disparities in Engagement Within HIV Care in South Africa" by Simbarashe Takuva of National Institute for Communicable Diseases, NHLS, Johannesburg, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25814.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25814.mp3</guid>	
 
<itunes:summary>Oral Abstract: Reaching Populations: Demonstrating Impact

"Disparities in Engagement Within HIV Care in South Africa" by Simbarashe Takuva of National Institute for Communicable Diseases, NHLS, Johannesburg, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Reaching Populations: Demonstrating Impact</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25815.mp3?mediaType=feedmp3</link>
<description>
"Decentralizing Access to Antiretroviral Therapy Services for Adults in Swaziland" by Andrew F. Auld of US Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25815.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25815.mp3</guid>	
 
<itunes:summary>Oral Abstract: Reaching Populations: Demonstrating Impact

"Decentralizing Access to Antiretroviral Therapy Services for Adults in Swaziland" by Andrew F. Auld of US Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Reaching Populations: Demonstrating Impact</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25816.mp3?mediaType=feedmp3</link>
<description>
"Who Are the 10-Year AIDS Survivors on Antiretroviral Therapy in Haiti?" by Samuel Pierre of Les Centres GHESKIO, Port-au-Prince, Haiti
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25816.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25816.mp3</guid>	
 
<itunes:summary>Oral Abstract: Reaching Populations: Demonstrating Impact

"Who Are the 10-Year AIDS Survivors on Antiretroviral Therapy in Haiti?" by Samuel Pierre of Les Centres GHESKIO, Port-au-Prince, Haiti

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Reaching Populations: Demonstrating Impact</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25817.mp3?mediaType=feedmp3</link>
<description>
"Nationwide Evaluation of Antiretroviral Therapy Coverage on Prevention in Rwanda: A Multisectional Time-Trend Analysis." by Sabin Nsanzimana of Rwanda Biomedical Centre, Kigali, Rwanda
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25817.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25817.mp3</guid>	
 
<itunes:summary>Oral Abstract: Reaching Populations: Demonstrating Impact

"Nationwide Evaluation of Antiretroviral Therapy Coverage on Prevention in Rwanda: A Multisectional Time-Trend Analysis." by Sabin Nsanzimana of Rwanda Biomedical Centre, Kigali, Rwanda

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Reaching Populations: Demonstrating Impact</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25818.mp3?mediaType=feedmp3</link>
<description>
"Impact of Male Circumcision Scale-Up on Community-Level HIV Incidence in Rakai, Uganda" by Xiangrong Kong of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25818.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25818.mp3</guid>	
 
<itunes:summary>Oral Abstract: Reaching Populations: Demonstrating Impact

"Impact of Male Circumcision Scale-Up on Community-Level HIV Incidence in Rakai, Uganda" by Xiangrong Kong of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Reaching Populations: Demonstrating Impact</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25819.mp3?mediaType=feedmp3</link>
<description>
"Effects of Antiretroviral Treatment on Health Care Utilization in Rural South Africa" by Jan A. Hontelez of Erasmus University Medical Center, Nijmegen, Netherlands
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25819.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25819.mp3</guid>	
 
<itunes:summary>Oral Abstract: Reaching Populations: Demonstrating Impact

"Effects of Antiretroviral Treatment on Health Care Utilization in Rural South Africa" by Jan A. Hontelez of Erasmus University Medical Center, Nijmegen, Netherlands

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Reaching Populations: Demonstrating Impact</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25820.mp3?mediaType=feedmp3</link>
<description>
"The Impact of PEPFAR Abstinence and Faithfulness Funding Upon HIV Risk Behaviors in Sub-Saharan Africa" by Nathan C. Lo of Stanford University School of Medicine, Stanford, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25820.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25820.mp3</guid>	
 
<itunes:summary>Oral Abstract: Reaching Populations: Demonstrating Impact

"The Impact of PEPFAR Abstinence and Faithfulness Funding Upon HIV Risk Behaviors in Sub-Saharan Africa" by Nathan C. Lo of Stanford University School of Medicine, Stanford, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Reaching Populations: Demonstrating Impact</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25821.mp3?mediaType=feedmp3</link>
<description>
"The Impact of Antiretroviral Therapy on Adult Life Expectancy in Sub-Saharan Africa" by Georges Reniers of London School of Hygiene and Tropical Medicine, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25821.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25821.mp3</guid>	
 
<itunes:summary>Oral Abstract: Reaching Populations: Demonstrating Impact

"The Impact of Antiretroviral Therapy on Adult Life Expectancy in Sub-Saharan Africa" by Georges Reniers of London School of Hygiene and Tropical Medicine, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Immune Mechanisms: The Road to Protection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25825.mp3?mediaType=feedmp3</link>
<description>
"Passively Acquired ADCC Activity in HIV-Infected Infants Correlates With Survival" by Caitlin Milligan of Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25825.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25825.mp3</guid>	
 
<itunes:summary>Oral Abstract: Immune Mechanisms: The Road to Protection

"Passively Acquired ADCC Activity in HIV-Infected Infants Correlates With Survival" by Caitlin Milligan of Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Immune Mechanisms: The Road to Protection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25826.mp3?mediaType=feedmp3</link>
<description>
"AAV-Expressed eCD4-Ig Protects Rhesus Macaques From Multiple SHIV-AD8 Challenges" by Michael Farzan of The Scripps Research Institute, Jupiter, FL, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25826.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25826.mp3</guid>	
 
<itunes:summary>Oral Abstract: Immune Mechanisms: The Road to Protection

"AAV-Expressed eCD4-Ig Protects Rhesus Macaques From Multiple SHIV-AD8 Challenges" by Michael Farzan of The Scripps Research Institute, Jupiter, FL, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Immune Mechanisms: The Road to Protection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25827.mp3?mediaType=feedmp3</link>
<description>
"HIV Neutralizing Antibodies Induced by Native-Like Envelope Trimers" by Rogier Sanders of Academic Medical Center University of Amsterdam, Amsterdam, Netherlands
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25827.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25827.mp3</guid>	
 
<itunes:summary>Oral Abstract: Immune Mechanisms: The Road to Protection

"HIV Neutralizing Antibodies Induced by Native-Like Envelope Trimers" by Rogier Sanders of Academic Medical Center University of Amsterdam, Amsterdam, Netherlands

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Immune Mechanisms: The Road to Protection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25828.mp3?mediaType=feedmp3</link>
<description>
"Efficacy Loss of BnAbs During HIV-1 Cell-Cell Spread Is Strain- and Epitope-Dependent" by Lucia Reh of University of Zurich, Zurich, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25828.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25828.mp3</guid>	
 
<itunes:summary>Oral Abstract: Immune Mechanisms: The Road to Protection

"Efficacy Loss of BnAbs During HIV-1 Cell-Cell Spread Is Strain- and Epitope-Dependent" by Lucia Reh of University of Zurich, Zurich, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Immune Mechanisms: The Road to Protection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25829.mp3?mediaType=feedmp3</link>
<description>
"Peripheral T Follicular Helper Cells With Universal Helper Activity in HIV Infection" by Hendrik Streeck of US Military HIV Research Program, Silver Spring, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25829.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25829.mp3</guid>	
 
<itunes:summary>Oral Abstract: Immune Mechanisms: The Road to Protection

"Peripheral T Follicular Helper Cells With Universal Helper Activity in HIV Infection" by Hendrik Streeck of US Military HIV Research Program, Silver Spring, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Immune Mechanisms: The Road to Protection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25830.mp3?mediaType=feedmp3</link>
<description>
"Redirected Killing of HIV-Infected T Cells by Germinal Center CD8 T Cells" by Constantinos Petrovas of Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25830.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25830.mp3</guid>	
 
<itunes:summary>Oral Abstract: Immune Mechanisms: The Road to Protection

"Redirected Killing of HIV-Infected T Cells by Germinal Center CD8 T Cells" by Constantinos Petrovas of Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Immune Mechanisms: The Road to Protection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25831.mp3?mediaType=feedmp3</link>
<description>
"IL-21 Reduces Inflammation and Virus Persistence in ART-Treated SIV-Infected Macaques" by Luca Micci of Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25831.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25831.mp3</guid>	
 
<itunes:summary>Oral Abstract: Immune Mechanisms: The Road to Protection

"IL-21 Reduces Inflammation and Virus Persistence in ART-Treated SIV-Infected Macaques" by Luca Micci of Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Immune Mechanisms: The Road to Protection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25832.mp3?mediaType=feedmp3</link>
<description>
"Discovery of CD8&lt;sup&gt;+ &lt;/sup&gt;T Cell Epitopes Encoded by the HIV 5’ Leader Sequence" by Edward Kreider of University of Pennsylvania, Philadelphia, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25832.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25832.mp3</guid>	
 
<itunes:summary>Oral Abstract: Immune Mechanisms: The Road to Protection

"Discovery of CD8&lt;sup&gt;+ &lt;/sup&gt;T Cell Epitopes Encoded by the HIV 5’ Leader Sequence" by Edward Kreider of University of Pennsylvania, Philadelphia, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Oral Abstract: Immune Mechanisms: The Road to Protection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/25833.mp3?mediaType=feedmp3</link>
<description>
"Neutralizing Antibodies Differ Between HIV-1–Infected RV144 Vaccinees and Placebos" by Shelly J. Krebs of US Military HIV Research Program, Silver Spring, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/25833.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/25833.mp3</guid>	
 
<itunes:summary>Oral Abstract: Immune Mechanisms: The Road to Protection

"Neutralizing Antibodies Differ Between HIV-1–Infected RV144 Vaccinees and Placebos" by Shelly J. Krebs of US Military HIV Research Program, Silver Spring, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


	
 
</channel>
</rss>
